Back to Results
First PageMeta Content
Amyotrophic lateral sclerosis / TARDBP / J. David Gladstone Institutes / James Heywood / Sean F. Scott / ALS Therapy Development Institute / Rare diseases / Health


ALS Therapy Development Institute and Gladstone Institutes Collaborate to Discover Potential ALS Treatments Institutes to Share Resources to Identify Potential Compounds Targeting TDP-43 Form of ALS CAMBRIDGE, MA and SAN
Add to Reading List

Document Date: 2012-12-04 10:54:53

Open Document

File Size: 483,90 KB

Share Result on Facebook

City

SAN FRANCISCO / CAMBRIDGE / /

Company

Gladstone Institutes / Biogen Idec / Gladstone Institutes Collaborate / ALS TDI / /

Country

United States / /

Facility

University of California / ALS Therapy Development Institute / /

IndustryTerm

potential pharmaceutical compounds / /

MedicalCondition

viral and neurological diseases / paralysis / Lou Gehrig’s disease / disease / neurodegenerative disease / ALS / lateral sclerosis / amyotrophic lateral sclerosis / /

Organization

MDA / RGK Foundation / Gladstone Institutes Gladstone / ALS Therapy Development Institute / Therapy Development Institute / University of California / San Francisco / /

Person

Shinya Yamanaka / Steve Perrin / Steve Finkbeiner / Lou Gehrig / /

Position

Investigator / professor of neurology / senior investigator / CEO and Chief Scientific Officer / /

ProvinceOrState

California / Massachusetts / /

Technology

stem cells / drug development / /

URL

www.gladstoneinstitutes.org / www.als.net / www.als.net/webinars / /

SocialTag